Market research
CCXI Churchill Capital Corp XI
NASDAQ USD Financial Services
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 812M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- Not available
Community
Investor discussion
1 comment
Sign in to join the CCXI discussion.
5 years, 4 months ago
ChemoCentryx, Inc is currently in a long term downtrend where the price is trading 67.5% below its 200 day moving average.
From a valuation standpoint, the stock is 96.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 51.9.
ChemoCentryx, Inc's total revenue sank by 55.9% to $4M since the same quarter in the previous year.
Its net income has dropped by 92.4% to $-30M since the same quarter in the previous year.
Finally, its free cash flow fell by 38.6% to $-28M since the same quarter in the previous year.
Based on the above factors, ChemoCentryx, Inc gets an overall score of 1/5.